Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide

Paul K. Fyfe, Vincenzo A. Rao, Aleksandra Zemla, Scott Cameron, William N. Hunter

    Research output: Contribution to journalArticle

    44 Citations (Scopus)

    Abstract

    TB or not TB active: The high-resolution crystal structures (see picture) of the zinccontaining metalloenzyme nicotinamidase in complex with nicotinic acid and pyrazinoic acid reveal new aspects of enzyme mechanism that help to explain the activation of a front-line anti-tuberculosis (TB) drug.

    Original languageEnglish
    Pages (from-to)9176-9179
    Number of pages4
    JournalAngewandte Chemie - International Edition
    Volume48
    Issue number48
    Early online date26 Oct 2009
    DOIs
    Publication statusPublished - 16 Nov 2009

    Fingerprint Dive into the research topics of 'Specificity and mechanism of <i>Acinetobacter baumanii </i>nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide'. Together they form a unique fingerprint.

    Cite this